Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 3
1998 4
2001 3
2002 8
2003 4
2004 4
2005 7
2006 4
2007 4
2008 6
2009 3
2010 5
2011 11
2012 10
2013 5
2014 10
2015 1
2016 5
2017 5
2018 1
2019 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Results by year
Filters applied: . Clear all
Page 1
Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy.
Goossens JF, Bailly C. Goossens JF, et al. Pharmacol Ther. 2019 Nov;203:107396. doi: 10.1016/j.pharmthera.2019.107396. Epub 2019 Jul 26. Pharmacol Ther. 2019. PMID: 31356908 Review.
Ursodeoxycholic acid (UDCA) is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism. ...
Ursodeoxycholic acid (UDCA) is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid b
Ursodeoxycholic acid and chemoprevention of colorectal cancer.
Serfaty L, Bissonnette M, Poupon R. Serfaty L, et al. Gastroenterol Clin Biol. 2010 Oct;34(10):516-22. doi: 10.1016/j.gcb.2010.05.005. Epub 2010 Jul 6. Gastroenterol Clin Biol. 2010. PMID: 20609543 Free article. Review.
Colorectal cancer is respectively the third and second most common cancer among men and women in France. Interest in chemoprevention for colorectal cancer has increased over the last two decades. Beside non-steroidal anti-inflammatory drugs, ursodeoxycholic acid
Colorectal cancer is respectively the third and second most common cancer among men and women in France. Interest in chemoprevention
Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis.
Magouliotis DE, Tasiopoulou VS, Svokos AA, Svokos KA, Chatedaki C, Sioka E, Zacharoulis D. Magouliotis DE, et al. Obes Surg. 2017 Nov;27(11):3021-3030. doi: 10.1007/s11695-017-2924-y. Obes Surg. 2017. PMID: 28889240 Review.
We aim to review the available literature on obese patients treated with ursodeoxycholic acid (UDCA) in order to prevent gallstone formation after bariatric surgery. ...
We aim to review the available literature on obese patients treated with ursodeoxycholic acid (UDCA) in order to prevent galls …
Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults.
Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Weir TL, et al. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013. PLoS One. 2013. PMID: 23940645 Free PMC article.
GC-MS profiling revealed higher concentrations of amino acids in stool samples from CRC patients and higher poly and monounsaturated fatty acids and ursodeoxycholic acid, a conjugated bile acid in stool samples from healthy adults (p<0.01). ...Using integr …
GC-MS profiling revealed higher concentrations of amino acids in stool samples from CRC patients and higher poly and monounsaturated fatty a …
Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment?
Solimando R, Bazzoli F, Ricciardiello L. Solimando R, et al. Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):555-68. doi: 10.1016/j.bpg.2011.09.004. Best Pract Res Clin Gastroenterol. 2011. PMID: 22122771 Review.
Chemoprevention of colorectal cancer has been an intense focus of research for many years. Among the possible candidate agents, ursodeoxycholic acid, folate, and hormone replacement therapy have been recently investigated with conflicting data. ...
Chemoprevention of colorectal cancer has been an intense focus of research for many years. Among the possible candidate agents, ur
CANCERPREVENTIVE IN ULCERATIVE COLITIS.
Podolskaya DV, Shapina MV, Khalif IL. Podolskaya DV, et al. Eksp Klin Gastroenterol. 2016;(8):4-8. Eksp Klin Gastroenterol. 2016. PMID: 29874428 Review. English, Russian.
That is the reason why methods of chemoprevention needs to influence on inflammation and other pathogenesis pathways. The role of such classes of medication as non-steroidal anti-inflammatory drugs, 5-aminosalicylic acid, immunomodulators, ursodeoxycholic
That is the reason why methods of chemoprevention needs to influence on inflammation and other pathogenesis pathways. The role of suc …
Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
Sjöqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Löfberg R. Sjöqvist U, et al. Anticancer Res. 2004 Sep-Oct;24(5B):3121-7. Anticancer Res. 2004. PMID: 15510599 Free article. Clinical Trial.
Recently, results from animal studies have shown that the bile acid ursodeoxycholic acid (UDCA) has a favourable impact on experimentally-induced CRC/neoplasia in rats. ...Prolonged treatment or an increased dose may be needed to fully exploit the chemopre
Recently, results from animal studies have shown that the bile acid ursodeoxycholic acid (UDCA) has a favourable impact …
Chemoprevention of colorectal cancer in inflammatory bowel disease.
Ehrlich AC, Patel S, Meillier A, Rothstein RD, Friedenberg FK. Ehrlich AC, et al. Expert Rev Anticancer Ther. 2017 Mar;17(3):247-255. doi: 10.1080/14737140.2017.1283987. Epub 2017 Feb 1. Expert Rev Anticancer Ther. 2017. PMID: 28095263 Review.
Areas covered: After conducting a PubMed search for relevant literature, we examined several classes of medications that have been studied as potential chemopreventive agents. These include 5-aminosalicylates, thiopurines, tumor necrosis factor antagonists, ursodeoxycho
Areas covered: After conducting a PubMed search for relevant literature, we examined several classes of medications that have been studied a …
Chemoprevention of colorectal cancer.
Das D, Arber N, Jankowski JA. Das D, et al. Digestion. 2007;76(1):51-67. doi: 10.1159/000108394. Epub 2007 Oct 19. Digestion. 2007. PMID: 17947819 Review.
More recently, case-control and cohort studies and well-conceived, phase II/III clinical trials have been done or are under way to evaluate putative chemopreventive agents including established drugs like aspirin and non-steroidal anti-inflammatory drugs (NSAIDs), 5-aminos …
More recently, case-control and cohort studies and well-conceived, phase II/III clinical trials have been done or are under way to evaluate …
Chemoprevention of colorectal cancer with ursodeoxycholic acid: cons.
Carey EJ, Lindor KD. Carey EJ, et al. Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S61-4. doi: 10.1016/S2210-7401(12)70023-2. Clin Res Hepatol Gastroenterol. 2012. PMID: 23141896
Animal and human data suggest a relationship between bile acids, especially secondary bile acids, and colorectal cancer. Ursodeoxycholic acid, a synthetic bile acid, has been shown in animal and in vitro studies to reduce the risk of colonic dysplasia and can …
Animal and human data suggest a relationship between bile acids, especially secondary bile acids, and colorectal cancer. Ursodeoxycholic
101 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page